Substances that can change alternative splice-site selection.
about
Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAsThe pathobiology of splicingA splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafishIdentification of a novel function of CX-4945 as a splicing regulatorSerine arginine splicing factor 3 is involved in enhanced splicing of glucose-6-phosphate dehydrogenase RNA in response to nutrients and hormones in liverPharmacologic correction of dominant-negative GH1 deficiency causing mutations.SpliceAid 2: a database of human splicing factors expression data and RNA target motifs.High-throughput binding analysis determines the binding specificity of ASF/SF2 on alternatively spliced human pre-mRNAs.Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy.The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region.Extensive alternative splicing of the repressor element silencing transcription factor linked to cancer.Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNAGene therapeutic approach using mutation-adapted U1 snRNA to correct a RPGR splice defect in patient-derived cells.Functional characterization of the spf/ash splicing variation in OTC deficiency of mice and man.Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and diseaseAON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation.Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.Alternative splicing and disease.Missed threads. The impact of pre-mRNA splicing defects on clinical practice.Emerging role of alternative splicing of CRF1 receptor in CRF signaling.RNA splicing: disease and therapy.Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing.Pyrvinium pamoate changes alternative splicing of the serotonin receptor 2C by influencing its RNA structure.Rapid-response splicing reporter screens identify differential regulators of constitutive and alternative splicing.The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing.Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.Intravitreal Injection of Splice-switching Oligonucleotides to Manipulate Splicing in Retinal Cells.RNA splicing meets genetic testing: detection and interpretation of splicing defects in genetic diseases.Regulation of alternative splicing within the supraspliceosome.Functional analysis and in vitro correction of splicing FAH mutations causing tyrosinemia type I.Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders.Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.
P2860
Q21134933-4836E83C-D98B-4569-A7B3-34CF413E17AAQ24634680-C4BE0308-BDF5-4EFE-975F-3EDEAD53E7A4Q27322025-2581B567-479E-4586-B34A-A97D86C78DE1Q28537999-251206C6-3D3E-4D2E-BF35-83CD0F3D6467Q28569550-11BD05CA-54DD-4E7D-B1A9-CB2FCC01D145Q33713445-D77C4542-35E9-43D3-AA23-25513D6FD924Q34020618-8CD19614-3DD8-4E93-B10E-8B23F45699B8Q34088421-7FE985FF-5134-4619-8973-FD53F4958933Q34616822-0D988394-D906-44B2-86FC-BCFBE5286265Q34626756-6D671AAE-974E-47CD-933E-455C87DF42F2Q34685755-0D519177-A0C9-45D2-A535-8191CC0FD731Q34695541-6539E97C-A245-44C4-9859-BE6E8393ED3CQ34994553-784C6AFB-A948-4B5B-9F6E-C7C0D5B55476Q35327051-F5747E0C-8AC5-4CC3-B86F-F5332778FC92Q35608609-97CFB5A1-F9B2-4327-92A9-136F3F418F14Q36077787-0FAD1A39-3423-45A0-8E62-24D4108C01A7Q36188228-B6A8B408-E742-4F5A-B4CC-79CDE6899088Q37320845-2E66EFFC-8586-4CDE-A3B1-9B0542D3A040Q37569558-6AF3E986-5FF6-4CD7-9D97-5E41D3CCAC83Q37710423-5811B7EE-1ADE-4511-A229-275A386C411AQ37882854-B711BAD2-B598-48E8-8CC7-BAB28E2DC728Q39323969-AB0790C3-8F89-4061-94D8-F0BA7683FC47Q39426973-48A825C4-F393-457B-B8F8-494EF53CA95AQ39587350-A9828079-CCE2-4697-8B2B-752CA5640F52Q39597984-6F2BAAC4-60EB-4869-B896-B408400ECD4EQ39608589-8D0A0A5F-5D01-4AF4-9521-A65DD62121FFQ39934103-8C1C0E82-FDE5-4FD7-8163-97D30A30B8BCQ40339014-CADC2A23-9FB1-42C3-A527-743E403B1A74Q40588004-67B69640-7982-4FD1-BB1F-9B928F0A6859Q42352620-37DD84DE-6F45-47F1-9944-161D76F93637Q42590242-7E753D90-06F6-424F-92B0-802BC6F4535BQ42611228-FB1E92E8-B908-4EDD-BB5B-B9C5B7B58BD4Q42718037-E5C2C5B7-CA06-4CD6-9935-5166BC6AA3F4Q50131827-BC028507-8974-4C53-80F3-8F57353294D6Q51715690-8581DBA3-0D4B-4C88-900C-3B0B71EAEDE4
P2860
Substances that can change alternative splice-site selection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Substances that can change alternative splice-site selection.
@en
Substances that can change alternative splice-site selection.
@nl
type
label
Substances that can change alternative splice-site selection.
@en
Substances that can change alternative splice-site selection.
@nl
prefLabel
Substances that can change alternative splice-site selection.
@en
Substances that can change alternative splice-site selection.
@nl
P2093
P356
P1476
Substances that can change alternative splice-site selection.
@en
P2093
Chiranthani Sumanasekera
David S Watt
Stefan Stamm
P304
P356
10.1042/BST0360483
P577
2008-06-01T00:00:00Z